FWIW how they’ve classified the numbers is appropriate including both the R&D, one off costs and cap raise costs.
R&D for a business like this is a legitimate operating inflow. Given it may not be recurring investors should consider adjusting their analysis but it’s not hard to look through that. I was shocked to see the big jump at the open. Nothing really new and a very average quarterly given the weaker sales growth.
Yes, LVT have marketed this at a high level incorrectly but that’s just fluff and anyone following the company can look through that.
While it screens ok atm, outside of a major positive catalyst between now and the end of the calendar year I see this getting below at least 27c IMO. The December quarterly is seriously huge for LVT. If growth returns there will be a violent re-rate. If not then the $100m ARR goal is at risk and the SP tanks outside of a takeover.
- Forums
- ASX - By Stock
- LVT
- Ann: Appendix 4C - 131% growth in ARR and record cash receipts
Ann: Appendix 4C - 131% growth in ARR and record cash receipts, page-48
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LVT (ASX) to my watchlist
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.474M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LVT (ASX) Chart |
Day chart unavailable
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online